Ascent Bio
PrivateLast Round
Accelerator
Nov 30, 2023
Total Funding Raised
$150,000
Company Overview
Ascent Bio operates in Healthcare & Life Sciences and is based in Los Alamitos, California. Its latest recorded funding round was an Accelerator round in November 2023.
Ascent Bio is a software company that develops an autonomous artificial intelligence platform for drug design and molecular optimization.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ascent Bio Comparables
Compare Ascent Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TandemAI | 78% | |
| Receptor.AI | 77% | |
| Alphabet Inc. | 77% |
For institutional investors. Book with your work email.
Ascent Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Ascent Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Digital Sciences Studio | Accelerator |
| Nucleate | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2024
Grew 100% QoQ from 3 to 6 employees.
For institutional investors. Book with your work email.
Ascent Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ascent Bio's valuation, stock price, and market status.
Is Ascent Bio a public or private company?
Ascent Bio is a private company.
What is the current stock price of Ascent Bio?
Ascent Bio is a private company, so its shares have no public market price. Caplight tracks Ascent Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ascent Bio worth (valuation)?
Valuation information for Ascent Bio is not publicly available.
Can I buy Ascent Bio stock?
Ascent Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ascent Bio's last funding round?
Ascent Bio's most recent funding round was Accelerator on November 30, 2023.
Who are the main investors in Ascent Bio?
Key investors in Ascent Bio include Merck Digital Sciences Studio, Nucleate.
Will Ascent Bio IPO soon?
No public IPO plans have been announced for Ascent Bio.
How can I track Ascent Bio secondary market activity?
Caplight tracks bids, offers, and trades in Ascent Bio's shares on secondary markets.